Condition

Clinical trials for Obese

Active public studies that list Obese as a condition.

29active studies

11recruiting now

13countries represented

16largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowPhase 2

Taxi ROADmAP (Realizing Optimization Around Diet And Physical Activity)

Overweight, Overweight and ObesityCondition

Counseling, Text MessagesTreatment

United States1 locations

Memorial Sloan Kettering Cancer CenterSponsor

Updated 2026-09-02 · NCT05770570See eligibility →

Recruiting nowPhase 3

Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary Syndrome

PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries, ObeseCondition

Semaglutide Injectable Product (Wegovy and/or Ozempic)Treatment

United States1 locations

University of Colorado, DenverSponsor

Updated 2026-08-31 · NCT05819853See eligibility →

Recruiting nowNot applicable

Mechanical Ventilation in Obese Surgical Patients

ObeseCondition

Standard PEEP (8 cmH₂O)Treatment

United States1 locations

The University of Texas Medical Branch, GalvestonSponsor

Updated 2026-08-19 · NCT07774065See eligibility →

Recruiting nowNot applicable

Trans-nasal Endoscopy for Bariatric Patients

Obesity, Obesity, MorbidCondition

Transnasal Endoscopy, EsophagogastroduodenoscopyTreatment

United States1 locations

Christopher C. Thompson, MD, MScSponsor

Updated 2026-06-25 · NCT06200961See eligibility →

Recruiting nowNot applicable

Effect of Combined Resisted Training and Protein-based Diet on Frailty in Sarcopenic Elderly Women

Obese, Sarcopenic ObesityCondition

supervised resistance exercise training and a, high -protein dietTreatment

Egypt1 locations

Cairo UniversitySponsor

Updated 2026-06-04 · NCT07627919See eligibility →

Recruiting nowPhase 1

A Single and Multiple Ascending Dose Study of HM17321 in Healthy and Obese Participants

Obesity, ObeseCondition

HM17321, Placebo of HM17321Treatment

United States1 locations

Hanmi Pharmaceutical Company LimitedSponsor

Updated 2026-05-04 · NCT07219589See eligibility →

Recruiting nowPhase 1

A Study Looking at How Weekly Injections of Two Hormones - GIP and Amylin - Affect Stomach-related Side Effects in People Who Are Overweight or Obese

Overweight, ObeseCondition

Glucose-dependent Insulinotropic Polypeptide (GIP), CagrilintideTreatment

United Kingdom1 locations

Novo Nordisk A/SSponsor

Updated 2026-04-13 · NCT07411560See eligibility →

Recruiting nowNot applicable

Exercise Response in Humans With Obesity

ObeseCondition

Treadmill Test, Strength TestTreatment

United States1 locations

Mayo ClinicSponsor

Updated 2025-08-29 · NCT05857150See eligibility →

Recruiting nowNot applicable

Dynamo: a Tailored Lifestyle Promotion Intervention Among Pediatric Patients With Cardiometabolic Risk Factors

ObeseCondition

Sensor based PA intervention, Traditional PA counselingTreatment

Canada1 locations

St. Justine's HospitalSponsor

Updated 2025-05-25 · NCT01736748See eligibility →

Recruiting nowNot applicable

Adipose Inflammation and Diabetes (FAB)

ObeseCondition

Intervention not listedTreatment

Sweden1 locations

Göteborg UniversitySponsor

Updated 2025-05-06 · NCT04255264See eligibility →

Recruiting nowNot applicable

Validity and Reliability of the 6-minute Pegboard Ring Test in Obese Individuals

Obese Patients, ObesityCondition

Patients with obesityTreatment

Turkey (Türkiye)1 locations

Selcuk UniversitySponsor

Updated 2024-09-19 · NCT06590584See eligibility →

Opening soonNot applicable

A Clinical Trial to Investigate the Safety and Efficacy of MB-1 on Metabolic Health in Overweight and Obese Adults

Obese, Overweight AdultsCondition

MB-1, PlaceboTreatment

Canada1 locations

ArraeSponsor

Updated 2026-06-30 · NCT07363148See eligibility →

Opening soonPhase 1

A Pharmacokinetic Study of HDM1005 Injection in Participants With Impaired Renal Function and Healthy Participants

Overweight, ObeseCondition

HDM1005Treatment

China1 locations

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.Sponsor

Updated 2026-05-08 · NCT07559240See eligibility →

Opening soonPhase 1

A Study of SA030 Injection in Overweight or Obese Participants

Obese, OverweightCondition

Dose escalation of SA030, Matching placebo of SA030Treatment

Australia1 locations

Suzhou Siran Biotechnology Co.,Ltd.Sponsor

Updated 2026-03-18 · NCT07479862See eligibility →

Opening soonNot applicable

Empowering Healthy Lifestyle Behavior to Prevent and Control Obesity in Young Adults

Obese, OverweightCondition

HealthyW8 Digital Twin of healthy lifestyle recommendationsTreatment

Locations pending0 locations

University of ÉvoraSponsor

Updated 2025-04-24 · NCT06943651See eligibility →

Opening soonNot applicable

Pilates Mat Exercises Training on Functional Performance in Middle Age Obese Women

ObeseCondition

pilates mat exercisesTreatment

Egypt1 locations

Badr UniversitySponsor

Updated 2025-01-16 · NCT06779383See eligibility →

Opening soonPhase 4

Efficacy of Henagliflozin for Weight Loss in Obesity Without Diabetes

Obese, Weight LossCondition

Henagliflozin, PlaceboTreatment

Locations pending0 locations

The First People's Hospital of ChangzhouSponsor

Updated 2024-01-22 · NCT06216340See eligibility →

Invitation onlyNot applicable

Dietary Sugar Absorptive Phenotype for Prediction of Weight Loss Outcome

Obese, HealthyCondition

Endoscopic biopsyTreatment

United States1 locations

Mayo ClinicSponsor

Updated 2025-09-10 · NCT05408728See eligibility →

Active, not recruitingNot applicable

Longitudinal Changes in Lower Extremity Alignment and Mechanical Axis Parameters After Bariatric Surgery in Patients With Morbid Obesity: A Prospective Observational Study

Obese, Limb DeformitiesCondition

Obese.Treatment

Turkey (Türkiye)1 locations

Marmara UniversitySponsor

Updated 2026-09-03 · NCT07794566See eligibility →

Active, not recruitingPhase 2

Aleniglipron Phase 2 in Type 2 Diabetes Mellitus

Obese, ObesityCondition

Aleniglipron, PlaceboTreatment

United States16 locations

Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure TherapeuticsSponsor

Updated 2026-04-27 · NCT07400588See eligibility →

Active, not recruitingPhase 2

Study to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes Mellitus

Obese, ObesityCondition

HM15275, Placebo of HM15275Treatment

United States14 locations

Hanmi Pharmaceutical Company LimitedSponsor

Updated 2026-04-08 · NCT07205900See eligibility →

Active, not recruitingNot applicable

Project 1: Diet and Exercise Modulate the Sperm Epigenome in Men

Healthy Lifestyle, ObeseCondition

Diet, ExerciseTreatment

United States1 locations

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical CenterSponsor

Updated 2026-03-10 · NCT04175678See eligibility →

Active, not recruitingNot applicable

Olive Oil Polyphenols and Cardiovascular Health Biomarkers

Healthy, Normal WeightCondition

High-polyphenol olive oil, Low-polyphenol olive oilTreatment

United States1 locations

University of California, DavisSponsor

Updated 2026-01-29 · NCT04149288See eligibility →

Active, not recruitingNot applicable

Brain Fuel - Morning Nutrition and Cognitive Function

Obese, HealthyCondition

High protein/low carbohydrate, High carbohydrate/low proteinTreatment

United States1 locations

Arkansas Children's Hospital Research InstituteSponsor

Updated 2025-10-20 · NCT03386396See eligibility →

Active, not recruitingNot applicable

The Expecting Study

Pregnancy, ObeseCondition

Exercise InterventionTreatment

United States1 locations

Arkansas Children's Hospital Research InstituteSponsor

Updated 2025-02-14 · NCT02125149See eligibility →

Active, not recruitingNot applicable

Comparative Evaluation of the Evolution of Arterial and Microcirculatory Endothelial Function in Obese Patients With Type-2 Diabetes Versus Non-diabetic Obese Patients After a First Bariatric Surgery

Bariatric Surgery, ObeseCondition

Vascularly biological assessment, Analysis of vasomotor endothelial functionTreatment

France1 locations

Centre Hospitalier Universitaire de NīmesSponsor

Updated 2025-01-07 · NCT03636243See eligibility →

Active, not recruitingNot applicable

Diet Intervention on Obesity Related Complication

Obese, Stomach DiseasesCondition

low linoleic acid (LA)Treatment

China1 locations

Zhang MannaSponsor

Updated 2024-12-05 · NCT06719466See eligibility →

Active, not recruitingPhase 2

A Study of Distal Jejunal-release Dextrose in Obese Participants

ObeseCondition

APHD-012, APHD-012PTreatment

Georgia, Germany9 locations

Aphaia Pharma US LLCSponsor

Updated 2024-10-16 · NCT05385978See eligibility →

Active, not recruitingPhase 1, Phase 2

Umbilical Cord Mesenchymal Stem Cell for Aging-related Low-grade Inflammation

Inflammatory Disease, Aging ProblemsCondition

umbilical cord mesenchymal stem cellTreatment

Vietnam1 locations

Nguyen Ton Ngoc HuynhSponsor

Updated 2024-06-07 · NCT06448052See eligibility →

Related conditions

Obesity1,102 Obesity & Overweight220 Overweight205 Overweight and Obesity130 Type 2 Diabetes108 Hypertension107

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.